BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹37 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr |
What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹37 Cr |
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹30 Cr |
How is Cash Flow from Operating Activities of BETA DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 3.16 | |
| Mar2025 | ₹36 Cr | 16.86 | |
| Mar2024 | ₹31 Cr | 32.28 | |
| Mar2023 | ₹23 Cr | -21.08 | |
| Mar2022 | ₹30 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,958.3 Cr | -2.9% | 6% | 8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -2.9% |
6% |
8.2% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses